keyword
Keywords Hormonal contraception side ef...

Hormonal contraception side effectS

https://read.qxmd.com/read/38106802/factors-used-by-mobile-applications-to-predict-female-fertility-status-and-their-reported-effectiveness-a-scoping-review
#21
REVIEW
Elaine E Saugar, Sabine Katsoulos, Hyun-Su Kim, Nazanin Fakharzadeh, Jacob Schaffer, Maubeen Ahmad, Caitlin Zeher, Meghan Benedict, Sarina Gupta, Gina Foster-Moumoutjis
Family planning, whether for pregnancy prevention or conception, is of pivotal importance to women of reproductive age. As hormonally driven methods, such as oral contraceptive pills, are widely used but have numerous side effects, women often seek alternative non-hormonal, non-invasive options, including fertility-tracking mobile applications (apps). However, the effectiveness of these apps as a method of contraception and conception planning has not been extensively vetted. The goal of this scoping review is to identify the various factors used by apps marketed as a method of contraception and/or family planning to predict a woman's fertility status, as well as their documented effectiveness...
November 2023: Curēus
https://read.qxmd.com/read/38103854/the-effect-of-a-single-dose-of-a-combination-injectable-contraceptive-for-treatment-of-bothersome-uterine-bleeding-in-contraceptive-implant-s-users-a-randomized-double-blind-placebo-controlled-trial
#22
JOURNAL ARTICLE
Natchanika Sinthuchai, Nitisa Tapanwong, Chayanis Apirakviriya, Natkrita Pohthipornthawat, Somsook Santibenchakul, Unnop Jaisamrarn
OBJECTIVE: To determine the proportion of participants whose uterine bleeding/spotting was interrupted for at least seven days during the month after they received a combined hormonal injection. We also evaluated bleeding at 21 days and 12 weeks after the injection. STUDY DESIGN: We conducted a randomized, double-blind, placebo-controlled trial in 46 contraceptive implant users who presented with bothersome uterine bleeding/spotting. A single dose of a combination injectable contraceptive or placebo was administered intramuscularly at enrollment...
December 14, 2023: Contraception
https://read.qxmd.com/read/38099900/a-3-year-retrospective-review-of-contraceptive-initiation-continuation-switching-and-pregnancy-among-adolescents-and-young-adults
#23
JOURNAL ARTICLE
Melissa J Kottke, Samuel F Aiyedipe, Peggy Goedken, Robert H Lyles, Megan McCool-Myers
PURPOSE: To understand contraceptive use patterns (initiation, switching, discontinuation) as well as associations with pregnancy in adolescents and young adults attending a teen family planning clinic. METHODS: We performed a chart review of adolescent and young adult patients (ages 12-20) attending a teen family planning clinic in Atlanta, GA between January 1, 2017, and December 31, 2019. Using a standardized abstraction form with quality controls, we collected available data on contraceptive methods used and pregnancy test results during the 3-year period...
December 14, 2023: Journal of Adolescent Health
https://read.qxmd.com/read/38088330/nanostrategy-of-targeting-at-embryonic-trophoblast-cells-using-cuo-nanoparticles-for-female-contraception
#24
JOURNAL ARTICLE
Zhenning Su, Cancan Yao, Joanne Tipper, Lijun Yang, Xiangbo Xu, Xihua Chen, Guo Bao, Bin He, Xiaoxue Xu, Yufeng Zheng
Effective contraceptives have been comprehensively adopted by women to prevent the negative consequences of unintended pregnancy for women, families, and societies. With great contributions of traditional hormonal drugs and intrauterine devices (IUDs) to effective female contraception by inhibiting ovulation and deactivating sperm, their long-standing side effects on hormonal homeostasis and reproductive organs for females remain concerns. Herein, we proposed a nanostrategy for female contraceptives, inducing embryonic trophoblast cell death using nanoparticles to prevent embryo implantation...
December 13, 2023: ACS Nano
https://read.qxmd.com/read/38082340/current-status-and-challenges-of-breast-cancer-prevention-dna-methylation-would-lead-to-groundbreaking-progress-in-breast-cancer-prevention
#25
REVIEW
Takahiro Tsukioki, Seema A Khan, Tadahiko Shien
The number of breast cancer patients is increasing worldwide. Furthermore, breast cancer often develops in young people, even those only in their 30s, who play a central role in their families and society. Results from many cohort studies suggest that dietary factors, alcohol consumption, lack of physical activity, obesity, nulliparity, breastfeeding, oral contraceptive use, fertility treatment and hormone replacement therapy are risk factors for breast cancer. However, the effects of lifestyle habits on the human body are complexly intertwined with various factors, and the effects vary from person to person depending on their constitution, etc...
December 12, 2023: Genes and Environment: the Official Journal of the Japanese Environmental Mutagen Society
https://read.qxmd.com/read/38012981/subdermal-progestin-implant-and-an-oral-combined-hormonal-contraceptive-in-youth-with-type-1-diabetes
#26
JOURNAL ARTICLE
Franco Giraudo, Abril Salinas, Paulina M Merino, Germán Iñiguez, Patricia López, Andrea Castro, María Cecilia Lardone, Gabriel Cavada, Fernando Cassorla, Ethel Codner
STUDY OBJECTIVE: To determine the metabolic effects of the subcutaneous etonogestrel implant compared to an oral contraceptive in adolescents and young adults (AYA) with T1D on body weight, body composition, glucose, lipids, and C-reactive protein levels (CRP). METHODS: Non-randomized, interventional, prospective study. Thirty-nine AYA with T1D participated; twenty used the implant (Implant-T1D), and nineteen used an oral combined contraceptive (OC-T1D). Body composition, HbA1c, intermittent continuous glucose monitoring (CGM), lipids, and high sensitivity C-reactive protein (hsCRP) levels were evaluated...
November 25, 2023: Journal of Pediatric and Adolescent Gynecology
https://read.qxmd.com/read/38002722/combined-hormonal-contraception-during-breastfeeding-a-survey-of-physician-s-recommendations
#27
JOURNAL ARTICLE
Lior Segev, Gideon Weitzman, Goldie Katz-Samson, Abraham O Samson, Guy Shrem, Naama Srebnik
Until breastfeeding is established, progesterone-only pill (POP) use is preferable over combined hormonal contraception (CHC), as the latter potentially reduces milk production. Yet, POPs are often associated with breakthrough bleeding (BTB), and irregular spotting is often a reason for their cessation. Conversely, CHC is less associated with BTB but is not usually prescribed, even if breastfeeding has been established, despite its verified safety profile. Here, we surveyed physicians' perception of CHC safety during breastfeeding through an online questionnaire (N = 112)...
November 15, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37975282/a-perspective-on-hormonal-contraception-usage-in-central-nervous-system-injury
#28
REVIEW
Hari Pradhyumnan, Gina G Perez, Shahil H Patel, Meghan O Blaya, Helen M Bramlett, Ami P Raval
Naturally occurring life stages in women are associated with changes in the milieu of endogenous ovarian hormones. Women of childbearing age may be exposed to exogenous ovarian hormone(s) because of their use of varying combinations of estrogen and progesterone hormones-containing oral contraceptives (OC; also known as "the pill"). If women have central nervous system (CNS) injury such as spinal cord injury (SCI) and traumatic brain injury (TBI) during their childbearing age, they are likely to retain their reproductive capabilities and may use OC...
March 2024: Journal of Neurotrauma
https://read.qxmd.com/read/37966030/dysmenorrhea-intermenstrual-bleeding-menstrual-flow-volume-changes-and-irregularities-following-covid-19-vaccination-and-the-association-with-vaccine-skepticism-a-retrospective-observational-study
#29
JOURNAL ARTICLE
Ghadeer A Khan, Alaa Althubaiti, Amal Alshrif, Zahra Alsayed, Hatim Jifree
BACKGROUND: COVID-19 vaccines have provided fertile ground for research, especially with the unprecedented spread of misinformation about this disease and its vaccines. Among women, one of the most frequently reported side effects of the vaccine has been menstrual disturbance. OBJECTIVE: To investigate the perceived impact of COVID-19 vaccines on the menstrual cycle. In addition, the research seeks to identify factors that could predispose certain individuals to experience these effects, thereby contributing to a deeper understanding of the interplay between vaccines and menstrual health...
2023: Women's Health
https://read.qxmd.com/read/37962925/analyzing-user-reviews-of-the-first-digital-contraceptive-mixed-methods-study
#30
JOURNAL ARTICLE
Marianela Ciolfi Felice, Marie Louise Juul Søndergaard, Madeline Balaam
BACKGROUND: People in Western countries are increasingly rejecting hormone-based birth control and expressing a preference for hormone-free methods. Digital contraceptives have emerged as nonhormonal medical devices that make use of self-tracked data and algorithms to find a user's fertile window. However, there is little knowledge about how people experience this seemingly new form of contraception, whose failure may result in unwanted pregnancies, high health risks, and life-changing consequences...
November 14, 2023: Journal of Medical Internet Research
https://read.qxmd.com/read/37941453/reversible-female-contraceptives-historical-current-and-future-perspectives
#31
JOURNAL ARTICLE
Brooke E Barton, Jeffery A Erickson, Stephanie I Allred, Jenna M Jeffries, Kalli S Stephens, Mark I Hunter, Kirby Woodall, Wipawee Winuthayanon
Contraception is a practice with extensive and complicated social and scientific histories. From cycle tracking, to the very first prescription contraceptive pill, to now having over-the-counter (OTC) contraceptives on demand, family planning is an aspect of healthcare that has undergone and will continue to undergo several transformations through time. This review provides a comprehensive overview of current reversible hormonal and non-hormonal birth control methods as well as their mechanism of action, safety, and effectiveness specifically for individuals who can become pregnant...
November 6, 2023: Biology of Reproduction
https://read.qxmd.com/read/37864676/evidence-based-recommendations-for-the-pharmacological-treatment-of-women-with-schizophrenia-spectrum-disorders
#32
REVIEW
Bodyl A Brand, Elske J M Willemse, Iris M H Hamers, Iris E Sommer
PURPOSE OF REVIEW: Despite clear evidence that sex differences largely impact the efficacy and tolerability of antipsychotic medication, current treatment guidelines for schizophrenia spectrum disorders (SSD) do not differentiate between men and women. This review summarizes the available evidence on strategies that may improve pharmacotherapy for women and provides evidence-based recommendations to optimize treatment for women with schizophrenia. RECENT FINDINGS: We systematically searched PubMed and Embase for peer-reviewed studies on three topics: (1) sex differences in dose-adjusted antipsychotic serum concentrations, (2) hormonal augmentation therapy with estrogen and estrogen-like compounds to improve symptom severity, and (3) strategies to reduce antipsychotic-induced hyperprolactinemia...
November 2023: Current Psychiatry Reports
https://read.qxmd.com/read/37863464/comparison-of-estrogenic-components-used-for-hormonal-contraception
#33
REVIEW
Frank Z Stanczyk, Sharon A Winer, Jean-Michel Foidart, David F Archer
Attempts have been made over the years to replace ethinyl estradiol (EE) in combined oral contraceptives (COCs) with the less potent natural estrogen estradiol (E2 ), or its prodrug, E2 valerate (E2 V), to improve their safety and tolerability. Recently, a COC incorporating a novel weak natural estrogen, estetrol (E4 ), combined with drospirenone, has become available. We present a comparative analysis of the three prevailing estrogens used in COCs, focusing on their structure-function relationships, receptor-binding affinity, potency, metabolism, pharmacokinetic parameters, and pharmacodynamics...
February 2024: Contraception
https://read.qxmd.com/read/37857350/combined-oral-contraceptives-update-recommendations-of-the-latin-american-contraceptive-association
#34
REVIEW
Santiago Palacios, Gabriela Ayala, Gemarilis González, Can L Badilla-Apuy, Jeannette Marchena, Katia Martínez, Desireé Mostajo, María S Vernaza, Alejandro Paradas, Luis Hernández, David Vásquez-Awad, Cuauhtémoc Celis-González, Nilson Roberto de Melo
Background: In recent years, new combined oral contraceptives (COCs) have become available, representing an advance in terms of individualization and compliance by users. Objective: To provide recommendations regarding COCs: formulations, use, efficacy, benefits and safety. Method: For these recommendations, we have used the modified Delphi methodology and carried out a systematic review of studies found in the literature and reviews performed in humans, published in English and Spanish in Pubmed, Medline and advanced medicine and computer networks until the year 2021, using the combination of terms: 'oral contraceptives', 'estroprogestins' and 'combined oral contraceptives'...
December 2023: Gynecological Endocrinology
https://read.qxmd.com/read/37837497/current-medical-therapy-for-adenomyosis-from-bench-to-bedside
#35
REVIEW
Andrea Etrusco, Fabio Barra, Vito Chiantera, Simone Ferrero, Stefano Bogliolo, Giulio Evangelisti, Engin Oral, Mariana Pastore, Alberto Izzotti, Renato Venezia, Marcello Ceccaroni, Antonio Simone Laganà
Adenomyosis, characterized by the growth of endometrial tissue within the uterine wall, poses significant challenges in treatment. The literature primarily focuses on managing abnormal uterine bleeding (AUB) and dysmenorrhea, the main symptoms of adenomyosis. Nonsteroidal anti-inflammatory drugs (NSAIDs) and tranexamic acid provide limited support for mild symptoms or symptom re-exacerbation during hormone therapy. The levonorgestrel-releasing intrauterine system (LNG-IUS) is commonly employed in adenomyosis management, showing promise in symptom improvement and reducing uterine size, despite the lack of standardized guidelines...
November 2023: Drugs
https://read.qxmd.com/read/37814343/the-progestin-revolution-2-progestins-are-now-a-dominant-player-in-the-tight-interlink-between-contraceptive-protection-and-bleeding-control-plus-more
#36
EDITORIAL
Donna Shoupe
The interlink between bleeding control and contraceptive development has always been an important factor. But after many years of advances in contraceptive technology, this interplay has resulted in development of safer and better contraceptive methods that often offer significantly less bleeding for women with both normal bleeding patterns as well as in those suffering from heavy menstrual bleeding (HMB). Recognition of the success of progestin-only methods, such as the hormonal IUDs, progestin dominant oral contraceptives, and the high dose progestin-only pill in substantially decreasing and controlling menstrual bleeding has led the way...
October 9, 2023: Contraception and Reproductive Medicine
https://read.qxmd.com/read/37794976/factors-affecting-recurrence-of-idiopathic-granulomatous-mastitis-a-systematic-review
#37
REVIEW
Asieh Sadat Fattahi, Ghasem Amini, Fatemeh Sajedi, Hassan Mehrad-Majd
Idiopathic granulomatous mastitis is a rare and benign disease that primarily affects young women of reproductive age. Various factors have been suggested as possible causes, including pregnancy, breastfeeding, history of taking birth control pills, hyperprolactinemia, smoking, and history of trauma. Due to unknown etiology, opinions on its treatment have varied, resulting in differing recurrence rates and side effects. Therefore, conducting a comprehensive systematic review and meta-analysis can aid in understanding the causes and recurrence of the disease, thereby assisting in the selection of effective treatment and improving the quality of life...
2023: Breast Journal
https://read.qxmd.com/read/37761027/clinical-approaches-to-nestorone-subdermal-implant-therapy-in-women-s-health
#38
REVIEW
Guilherme Renke, Consuelo Callizo, Raphaela Paes, Mariana Antunes, Glaycon Michels, Luana Concha, Ordânio Almeida, Christiane Valente, Thomaz Baesso, Bruna Giovannoni
Segesterone acetate (SA) or Nestorone, a fourth-generation progestogen, is a synthetic compound with high progestational activity and no androgenic, glucocorticoid, or anabolic effects. However, due to its oral inactivity, SA must be used by other routes, such as subcutaneous. Thus, considering its peculiar properties, the SA subdermal implant is successfully used in female contraception and postmenopausal hormone replacement therapy (HRT). In recent years, its potential uses in endometriosis, polycystic ovaries syndrome (PCOS), and a new therapeutic possibility for neuroprotection have made this treatment extremely interesting...
September 21, 2023: Biomedicines
https://read.qxmd.com/read/37741998/tolerability-of-endometriosis-medical-treatment-a-comparison-between-combined-hormonal-contraceptives-and-progestins
#39
JOURNAL ARTICLE
Denise Joffily Pereira da Costa Pinheiro, Ana Maria Gomes Pereira, Marcelo Antonini, Isabella Maria Albuquerque Salgado, Alexandre Torchio Dias, Reginaldo Guedes Coelho Lopes
Endometriosis is a chronic inflammatory disease that occurs in women of reproductive age. Much of the treatment involves hormone therapy that suppresses the proliferation of endometriosis lesions.Objective To compare discontinuation rates of pharmacological treatment with estrogen-progestins and progestins medications. The secondary objective is to evaluate the main side effects of these drugs in patients with endometriosis.Methods This retrospective study analyzed data from 330 patients who attended the Hospital of the State Public Servant of São Paulo from August 1999 to September 2020 and received pharmacological treatment for endometriosis...
September 23, 2023: BMC Women's Health
https://read.qxmd.com/read/37599373/hormonal-and-natural-contraceptives-a-review-on-efficacy-and-risks-of-different-methods-for-an-informed-choice
#40
REVIEW
Andrea R Genazzani, Tiziana Fidecicchi, Domenico Arduini, Andrea Giannini, Tommaso Simoncini
The debate about contraception has become increasingly important as more and more people seek safe and effective contraception. More than 1 billion women of reproductive age worldwide need a method of family planning, and wellbeing, socio-economic status, culture, religion and more influence the reasons why a woman may ask for contraception. Different contraceptive methods exist, ranging from 'natural methods' (fertility awareness-based methods - FABMs) to barrier methods and hormonal contraceptives (HCs). Each method works on a different principle, with different effectiveness...
December 2023: Gynecological Endocrinology
keyword
keyword
86142
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.